These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 7933088)
1. Improved self-inactivating retroviral vectors derived from spleen necrosis virus. Olson P; Nelson S; Dornburg R J Virol; 1994 Nov; 68(11):7060-6. PubMed ID: 7933088 [TBL] [Abstract][Full Text] [Related]
2. Unusually high frequency of reconstitution of long terminal repeats in U3-minus retrovirus vectors by DNA recombination or gene conversion. Olson P; Temin HM; Dornburg R J Virol; 1992 Mar; 66(3):1336-43. PubMed ID: 1310753 [TBL] [Abstract][Full Text] [Related]
3. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Yu SF; von Rüden T; Kantoff PW; Garber C; Seiberg M; Rüther U; Anderson WF; Wagner EF; Gilboa E Proc Natl Acad Sci U S A; 1986 May; 83(10):3194-8. PubMed ID: 3458176 [TBL] [Abstract][Full Text] [Related]
4. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat. Robinson D; Elliott JF; Chang LJ Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987 [TBL] [Abstract][Full Text] [Related]
5. E- vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy. Julias JG; Hash D; Pathak VK J Virol; 1995 Nov; 69(11):6839-46. PubMed ID: 7474097 [TBL] [Abstract][Full Text] [Related]
6. Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site. Choulika A; Guyot V; Nicolas JF J Virol; 1996 Mar; 70(3):1792-8. PubMed ID: 8627702 [TBL] [Abstract][Full Text] [Related]
8. Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration. Logan AC; Haas DL; Kafri T; Kohn DB J Virol; 2004 Aug; 78(16):8421-36. PubMed ID: 15280451 [TBL] [Abstract][Full Text] [Related]
9. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression. Couture LA; Mullen CA; Morgan RA Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129 [TBL] [Abstract][Full Text] [Related]
10. A new family of murine retroviral vectors with extended multiple cloning sites for gene insertion. Faustinella F; Kwon H; Serrano F; Belmont JW; Caskey CT; Aguilar-Cordova E Hum Gene Ther; 1994 Mar; 5(3):307-12. PubMed ID: 8018745 [TBL] [Abstract][Full Text] [Related]
11. The U3 region is not necessary for 3' end formation of spleen necrosis virus RNA. Iwasaki K; Temin HM J Virol; 1990 Dec; 64(12):6329-34. PubMed ID: 1700836 [TBL] [Abstract][Full Text] [Related]
12. Importance of 3' non-coding sequences for efficient retrovirus-mediated gene transfer in avian cells revealed by self-inactivating vectors. Flamant F; Aubert D; Legrand C; Cosset FL; Samarut J J Gen Virol; 1993 Jan; 74 ( Pt 1)():39-46. PubMed ID: 8380836 [TBL] [Abstract][Full Text] [Related]
13. Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo. Okuyama T; Huber RM; Bowling W; Pearline R; Kennedy SC; Flye MW; Ponder KP Hum Gene Ther; 1996 Mar; 7(5):637-45. PubMed ID: 8845389 [TBL] [Abstract][Full Text] [Related]
14. Self-inactivating lentiviral vectors with U3 and U5 modifications. Iwakuma T; Cui Y; Chang LJ Virology; 1999 Aug; 261(1):120-32. PubMed ID: 10441560 [TBL] [Abstract][Full Text] [Related]
15. Multiple modifications allow high-titer production of retroviral vectors carrying heterologous regulatory elements. Hlavaty J; Stracke A; Klein D; Salmons B; Günzburg WH; Renner M J Virol; 2004 Feb; 78(3):1384-92. PubMed ID: 14722293 [TBL] [Abstract][Full Text] [Related]
16. The U3 region of Moloney murine leukemia virus contains position-independent cis-acting sequences involved in the nuclear export of full-length viral transcripts. Volkova NA; Fomina EG; Smolnikova VV; Zinovieva NA; Fomin IK J Biol Chem; 2014 Jul; 289(29):20158-69. PubMed ID: 24878957 [TBL] [Abstract][Full Text] [Related]
17. Engineered long terminal repeats of retroviral vectors enhance transgene expression in hepatocytes in vitro and in vivo. Yamaguchi K; Itoh K; Ohnishi N; Itoh Y; Baum C; Tsuji T; Nagao T; Higashitsuji H; Okanoue T; Fujita J Mol Ther; 2003 Nov; 8(5):796-803. PubMed ID: 14599813 [TBL] [Abstract][Full Text] [Related]
18. Co-packaging of non-vector RNAs generates replication-defective retroviral vector particles: a novel approach for blocking retrovirus replication. Joshi S; Ding SF; Liem SE Nucleic Acids Res; 1997 Aug; 25(16):3199-203. PubMed ID: 9241231 [TBL] [Abstract][Full Text] [Related]
19. Effect of deletion and the site of insertion in double copy anti-tat retroviral vectors: viral titres and production of anti-tat mRNA. Carr JM; Calvert JK; Kumar R; Burrel CJ; Li P Arch Virol; 2001; 146(11):2191-200. PubMed ID: 11765920 [TBL] [Abstract][Full Text] [Related]
20. Development of a self-inactivating lentivirus vector. Miyoshi H; Blömer U; Takahashi M; Gage FH; Verma IM J Virol; 1998 Oct; 72(10):8150-7. PubMed ID: 9733856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]